Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Coherus BioSciences Inc.

Latest From Coherus BioSciences Inc.

Dr Reddy’s De Vré On Momentum In US Biosimilars Market, Interchangeability

The global head of Dr Reddy’s biologics business unit, Raymond De Vré, discusses in an interview with Scrip how things are looking up in the US biosimilars market, why interchangeability isn’t a major concern and how galloping volume growth is being seen by the company in emerging markets.

Biosimilars Commercial

Apotex Mystery: Why Has Accord BioPharma Taken Its Place In US Biosimilar Pegfilgrastim Litigation?

Court grants request to substitute Accord BioPharma for Apotex in Amgen infringement suit. Apotex says it has no plans to exit the biosimilar business.

Biosimilars Legal Issues

Mylan's Aflibercept Biosimilar Gets Green Light For Trials In India

Mylan’s proposal to progress studies for its aflibercept biosimilar has been endorsed by an expert panel in India, which expects availability of such biosimilars to expand access to anti-VEGF therapies.

Biosimilars Strategy

Genentech Is Second Biologic Titan To Resolve Trade Secret Suit; Former Employees Still On Hook

Genentech reaches memorandum of understanding with JHL Biotech involving four biosimilars while continuing its suit against former employees; Amgen settlement with Coherus ended litigation entirely.

Intellectual Property Biosimilars
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Dermatology
  • Gastrointestinal
  • Immune Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Ophthalmic
  • Alias(es)
  • BioGenerics Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Coherus BioSciences Inc.
  • Senior Management
  • Dennis Lanfear, Chmn., Pres. & CEO
    Jean-Frederic Viret, PhD, CFO
    Vladimir Vexler, PhD, CSO
    Darlene Horton, MD, CMO & Chief Reg. Affairs Officer
    Vince Anicetti, COO
    Erik Wiberg, VP, Corp. Dev.
  • Contact Info
  • Coherus BioSciences Inc.
    Phone: (800) 794-5434
    333 Twin Dolphin Dr., Ste. 600
    Redwood City, CA 94065